Investigator site

Brussels 1200

0 studies enrolling now · 5 studies all time

What they study most

Acquired Thrombotic Thrombocytopenic Purpura, Rheumatoid Arthritis

Studies at this site

• Phase III Trial With Caplacizumab in Patients With Acquired Thrombotic Thrombocytopenic Purpura — Completed
• Study to Assess Efficacy and Safety of Anti-von Willebrand Factor (vWF) Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (aTTP) — Completed
• Follow-up Study for Patients Who Completed Study ALX0681-C301 (Post-HERCULES) — Completed
• A Phase IIb Study for ALX-0061 Monotherapy in Subjects With Rheumatoid Arthritis — Completed
• A Dose-Range Finding Study for ALX-0061 Combination Therapy in Subjects With Rheumatoid Arthritis — Completed